Canopy Growth Corp (WEED)

[Wo]

Catalyst: A Cannabis Based Solution has been approved by the FDA for pharmaceutical distribution in the USA. Does this affect the Global Cannabis Industry or Canopy Growth? How does this change the rhetoric/ conversation around the scheduling of Cannabis in America as to having “ No medicinal benefits ?” .

GW Pharmaceuticals plc and its U.S. Subsidiary Greenwich Biosciences Announce FDA Approval of EPIDIOLEX® (cannabidiol) oral solution – the First Plant-derived Cannabinoid Prescription Medicine

GlobeNewswireJune 25, 2018

https://finance.yahoo.com/news/gw-pharmaceuticals-plc-u-subsidiary-165729968.html?.tsrc=applewf

First Marijuana-Based Medicine Is Approved for Sale in U.S.

June 25, 2018

https://finance.yahoo.com/m/e9c9622e-ec92-314c-bcf3-8c387a44926e/first-marijuana-based.html?.tsrc=applewf

GW Pharma wins U.S. approval for marijuana-derived epilepsy drug
Reuters
ReutersJune 25, 2018
June 25 (Reuters) - An epilepsy treatment from GW Pharmaceuticals Plc on Monday secured an approval from the U.S. Food and Drug Administration, becoming the first cannabis-based drug to be approved in the country.

https://finance.yahoo.com/news/gw-pharma-wins-u-approval-164208925.html?.tsrc=applewf


GW Pharma's Epidiolex Becomes First Cannabis-Based FDA-Approved Drug
Elizabeth Balboa
Elizabeth Balboa
BenzingaJune 25, 2018

https://finance.yahoo.com/news/gw-pharmas-epidiolex-becomes-first-170614533.html?.tsrc=applewf